RBC
EXAS

Romano Brothers & Co’s Exact Sciences EXAS Stock Holding History

Romano Brothers & Co’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-350
Closed -$17.3K – 505
2022
Q4 		$17.3K Buy
+350
New +$14.3K ﹤0.01% 640

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Romano Brothers & Co's EXAS Position: Q1 2023 in Review

Romano Brothers & Co sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 350 shares — an estimated $17.3K sold.

Romano Brothers & Co first reported a position in EXAS in Q4 2022 and held it in 1 quarter. The position peaked at $17.3K in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Romano Brothers & Co reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Romano Brothers & Co sold 350 Exact Sciences shares in Q1 2023, an estimated $17.3K.
  • Romano Brothers & Co first reported a position in Exact Sciences in Q4 2022 and held it in 1 quarter.
  • Romano Brothers & Co's Exact Sciences position peaked at $17.3K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.